CBIS CANNABIS SCIENCE, INC.

Theboundbook

Registered User
Forum Member
Jan 16, 2002
32,998
25
0
54
Salt Lake City, Utah
Got in this for 6.4 cents a share earlier today.... JUST BLIND DUMB LUCK, A&E Television announces an 8 episode reality show about this company.... CHACHING!!!


Oh, yes, this IS THAT CANNABIS PENNY STOCK...

This will pop a dime EASILY DURING THE A&E showings which is in the article:


Mom,

Here is some of the emails I sent out on this penny stock that has to do with marijuana science and how its legal and regulated big time in colorado... 30 minutes after I bought it, the A&E Television announced their reality show coming out about this COmpany and stock... Instantly it went from 6.4 cents and has hit 8 cents and is around, holy shit 8.2 cents! New HIght on the day..... 150 bucks was all.... Up huge now!

My final cost per share is .064... I forwarded what I had sent out twice, but put 500 in on this right now....



I am in at .064/share.... It is up 46.63% appx so far today, putting me up about 35% in 2 HOURS OF OWNING IT!!!! THIS IS HOW I DO IT.... GONNA SWELL HALF OF THIS IF IT HITS MY "GOAL".... Kicking myself for passing up on this one 3 days ago when it was like 4 cents a share..... I was deciding what to do to fill my "High Risk/High Yield Gambling Money (never more then 500)

Here is an interesting article:


http://thestockmarketwatch.com/news...proval-process-is-making-this-a-monster-play/

AND THEN JUST BY DUMB LUCK TODAY, THIS CAME OUT@!@@@ AND IM UP 33%-40% INSTANTLY NOW!!!!

A&E Begins Filming An 8-episode Documentary With Cannabis Science?s Newly Appointed Director of Horticulture Bret Bogue; Focused On Bret Bogue, World Renowned Medical Cannabis Cultivator

DENVER--(BUSINESS WIRE)--

Cannabis Science, Inc. (OTCBB:CBIS.OB) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) critical ailment formulations, is excited to announce the appointment of world renowned Cannabis Cultivator Bret Bogue as Director of Horticulture for the company. Mr. Bogue is a valuable addition to the company, with decades of experience growing cannabis for medical purposes.

Mr. Bogue will play a key role in the development and maintenance of all horticulture operations for the company while developing specific strains for mass production for the company?s growing standards and critical ailment formulations developed by the company. Mr. Bogue will be a part of the lead development team for plants and strains to be used to develop these medical cannabis formulations and products for Cannabis Science.

Being a critical cancer patient himself, Mr. Bogue was diagnosed with a very rare form of melanoma in 1995. Mr. Bogue*stated, "I became very ill and was looking for an alternative medication for my illness, so*I realized then that I needed to create Apothecary? Genetics to provide an alternative treatment solution*in the early 90s.*Through my world travels, I have been able to find ?land race strains? and breed them with hybrids to create World Class medical cannabis.?

Bret and Apothecary went on to become the first American-based seed company to win the coveted Cannabis Cup in Amsterdam in 2007, and has won many other international and national awards for his medical cannabis developments. Having over 20 years of experience creating unique medical strains of cannabis, such as Grape Ape aka GDP, Kaia Kush, Sour Grapes, Old School Jams, and Goo, just to name a few, has put Bret and Apothecary Genetics on the world map as one of the top leaders in medical cannabis development.

Mr. Bogue concludes with, ? I*was able to cure my melanoma by using medical cannabis in combination with standard radiation treatment. I am the living proof that medical cannabis kills cancer cells.?

As well, Bret is embarking on some exciting new projects such as a documentary with television giant A&E. Two pilots have already been filmed and sent to New York for review and approvals. The documentary will show real patients who are having real, positive results with medical cannabis. These patients include seniors from a senior citizens? community in California. Viewers will see the reality of the medication?s benefits, as well as the emotions that come into play when someone is chronically ill.
 

Theboundbook

Registered User
Forum Member
Jan 16, 2002
32,998
25
0
54
Salt Lake City, Utah
ENDED UP CLOSING AT .092!!!! THANK YOU!!!!! STOCK WENT UP 62% TODAY (last 20 minutes of the day the stock blew up going up 20% MORE AND LOOKS TO ME LIKE A SHITLOAD OF ORDERS TO BUY MORE WILL HIT 1st THING IN THE MORNING SINCE THERE ISN'T AFTER HOURS TRADING... I figure it might hit a dime 1st thing 2mor morning and then, like when it hit .08 today, resistance and quick profit taking; (I will be one of them), but I will buy back in, including profits after she "bottoms" out for the day and the gains start again... (figure itll drop to high sevens at lowest point after it hits .10 and the day traders take their profits from Wed) That's what Im betting on....
 

Theboundbook

Registered User
Forum Member
Jan 16, 2002
32,998
25
0
54
Salt Lake City, Utah
AND 2 HOURS LATER, RIGHT BACK UP to MY 9.0 range... SO I DID THIS ONE PERFECTLY!!!! Here some other great news about this:

everyone waiting for results from the biopsy from cancer patients which they said in an earlier press release that it will be announced by the end of the month.
 

Theboundbook

Registered User
Forum Member
Jan 16, 2002
32,998
25
0
54
Salt Lake City, Utah
MORE NEWS!!!

MORE NEWS!!!

great job theboundbook. you will like this more news

Cannabis Science, Inc. (OTCBB:CBIS.OB - News) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products is monitoring the outstanding progress of the 3rd Self-Medicated Cannabis Patient with Clear Continued Improvement. This self-medicating patient has what his doctors describe as the worst case of squamous cell carcinoma the had ever seen. This patient?s tumors, while resistant to conventional treatment, continues to make obvious improvement with the use of cannabis extracts.

Figure 1 shows the tumor from the last treatment on the left side of the patient?s head, scabbing over and healing. A cavernous opening began to form, and the roof and sides of the tumor have degraded and fallen off, as shown in Figure 2. Figures 3 and 4 show the tumor from above, and it is clear that the tumor continues to degrade.

On the right side of the patient?s head, the tumor is also slowly healing from the application of the cannabis-based extracts. The last three pictures show the absorption and killing of the tumor by the extract.

You can view these graphic photos on the Cannabis Science website www.cannabisscience.com and click the button ?View Images of 3rd Self-Medicated Patient & His Apparent Success.?

Cannabis Science continues to focus on cancer as a major initial target for treatment with its critical ailment formulations. Cannabis Science has provided the scientific foundation for numerous patients suffering from cancer to make the informed decision to treat themselves with cannabis extracts. The company has seen vast improvement in four out of patients with skin cancer to date who we have been scientifically advising. Their photo-documentation is available on the Cannabis Science website www.cannabisscience.com and click on the breaking news button where you will find all the cancer related and updated patient news.

About Cannabis Science, Inc.

Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.

The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
 

Theboundbook

Registered User
Forum Member
Jan 16, 2002
32,998
25
0
54
Salt Lake City, Utah
ANOTHER NICE DAY WITH MORE GREAT NEWS

ANOTHER NICE DAY WITH MORE GREAT NEWS

I am already up another 15.91% today, 26+% overall on this "2nd round" (bought and sold a 25+% the 1st day I got the stock and then waited and bought 1.2 cents/share prior) of quick and easy dough... Gonna hold this a little longer then 1 day.... Looking for .12 today, and then sell....

Here's the NEWS FOR TODAY:


Cancer Drug Market Evolves - Cannabis Science and ARIAD Pharmaceuticals Poised to Benefit
8:21a ET February 27, 2012 (Market Wire)
Advances in cancer screening and treatment has caused the death rate from cancer to drop dramatically in recent years. Cancer death rates dropped by 1.8 percent per year in men and 1.6 percent per year in women between 2004 and 2008, according to the American Cancer Society's annual report on cancer statistics. The Paragon Report examines investing opportunities in the Healthcare sector and provides equity research on Cannabis Science Inc. (OTCBB: CBIS) & ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA). Access to the full company reports can be found at:

www.paragonreport.com/CBIS

www.paragonreport.com/ARIA

Death rates fell in all four of the most common cancers, lung, colon, breast and prostate, with lung cancer accounting for nearly 40 percent of the total drop in men and breast cancer account for 34 percent of the total decline in women, the American Cancer Society report finds.

The U.S. FDA has been approving cancer drugs at a faster rate than its European counterpart (the EMA), Friends of Cancer Research reports. Between 2003 and 2010, the FDA not only approved more new cancer drugs than did the EMA, it approved these drugs more quickly: of 23 drugs approved by both agencies, the median time from marketing submission to FDA approval was 182 days vs. EMA approval of 350 days according to the report.

The Paragon Report provides investors with an excellent first step in their due diligence by providing daily trading ideas, and consolidating the public information available on them. For more investment research on the Healthcare sector register with us free at www.paragonreport.com and get exclusive access to our numerous stock reports and industry newsletters.

ARIAD Pharmaceuticals' product pipeline includes Ponatinib, a pan BCR-ABL inhibitor in phase 2 clinical trial for applications in various hematological cancers and solid tumors; and AP26113, an anaplastic lymphoma kinase (ALK) inhibitor in preclinical studies for the treatment of various cancers, including non-small cell lung cancer, lymphoma, and neuroblastoma.

Cannabis Science, Inc., a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products. Earlier this month the company introduced a fourth cancer patient with basal cell carcinoma (skin cancer) on his left nostril, who is self-administering a topical cannabis extract and having noticeable results.

The Paragon Report has not been compensated by any of the above-mentioned publicly traded companies. Paragon Report is compensated by other third party organizations for advertising services. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at http://www.paragonreport.com/disclaimer

SOURCE: Paragon Financial Limited



 

Theboundbook

Registered User
Forum Member
Jan 16, 2002
32,998
25
0
54
Salt Lake City, Utah
UP OVER 50% today!!!! And 25% yesterday! Just sold it all at .1572...


Looking for a good spot to get back in... Hopefully around .14 now that profit taking has started.. Its all in the timing...
 

Theboundbook

Registered User
Forum Member
Jan 16, 2002
32,998
25
0
54
Salt Lake City, Utah
UP OVER 50% today!!!! And 25% yesterday! Just sold it all at .1572...


Looking for a good spot to get back in... Hopefully around .14 now that profit taking has started.. Its all in the timing...

And RIGHT BACK IN AT .147 (made a quick penny/share 49000 shares, hehe.....) Stock is heading back up now!!!! (ABOVE .1510)
 
Last edited:
Bet on MyBookie
Top